ClinConnect ClinConnect Logo
Search / Trial NCT06071494

The Effect Of Tropical Fruits In Patients With Primary Glaucoma

Launched by UNIVERSITI SAINS MALAYSIA · Oct 1, 2023

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking into how eating tropical fruits regularly might help patients with primary glaucoma, a condition that affects the eyes and can lead to vision loss. The study will take place from February 2024 to June 2025 at the Ophthalmology Clinic in Hospital Universiti Sains Malaysia, and it is currently recruiting participants. To be eligible, you need to have a confirmed diagnosis of primary open-angle glaucoma or primary angle-closure glaucoma, have been on medication for at least six months, and be successfully managing your eye pressure. However, if you have poorly controlled diabetes, high blood pressure, or other specific health issues, you may not qualify.

If you decide to participate, you can expect to be part of a randomized controlled trial, which means you might receive either the tropical fruits or standard care. This trial is important because it may provide insights into how diet can play a role in managing glaucoma. Remember, this study welcomes all adults with the condition, and your involvement could contribute to understanding better ways to help people with glaucoma.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patient with confirmed diagnosis of POAG and PACG
  • 2. Patient on medical treatment and achieved target IOP in last 6 months
  • 3. Good compliance with pressure lowering agents
  • Exclusion Criteria:
  • 1. Poorly controlled diabetes mellitus, hypertension and hyperlipidaemia
  • 2. Active smoker
  • 3. Mentally challenge based on diagnosis
  • 4. History of previous intraocular surgery other than uncomplicated cataract surgery within past 6 months
  • 5. Poor signal strength OCT RNFL
  • 6. Patient with media opacities that affect the reliability of OCT measurements , such as Cornea opacity, dense cataract with LOCS III of more than grade 2, vitreous haemorrhage
  • 7. Other optic neuropathy apart from glaucoma
  • 8. History of taking antioxidant supplement 3 months prior to recruitment

About Universiti Sains Malaysia

Universiti Sains Malaysia (USM) is a leading research university in Malaysia, renowned for its commitment to advancing scientific knowledge and innovation in the healthcare sector. As a clinical trial sponsor, USM leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous research aimed at improving patient outcomes and addressing pressing health challenges. The university fosters collaboration among researchers, medical professionals, and industry partners, ensuring that its clinical trials are conducted with the highest ethical standards and scientific integrity. Through its dedication to excellence in research and education, USM plays a pivotal role in shaping the future of healthcare both locally and globally.

Locations

Kubang Kerian, Kota Bharu, Malaysia

Patients applied

0 patients applied

Trial Officials

Nurul Munirah Mohamad, Dr

Principal Investigator

Department of Ophthalmology School of Medical Sciences Universiti Sains Malaysia,Health Campus.

Liza Sharmini Ahmad Tajudin, Prof. Dr.

Study Chair

Department of Ophthalmology School of Medical Sciences Universiti Sains Malaysia,Health Campus.

Rohana Abd Jalil, Ass. Prof.

Study Director

Department of Ophthalmology School of Medical Sciences Universiti Sains Malaysia,Health Campus.

Fatimah Suhaila Sukaimy, Dr

Study Director

Department of Ophthalmology Hospital Tengku Ampuan Afzan, Ministry of Health, Malaysia

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported